U.S. Markets open in 7 hrs 40 mins
  • S&P Futures

    3,672.25
    +7.75 (+0.21%)
     
  • Dow Futures

    29,990.00
    +58.00 (+0.19%)
     
  • Nasdaq Futures

    12,506.75
    +44.50 (+0.36%)
     
  • Russell 2000 Futures

    1,850.90
    +3.70 (+0.20%)
     
  • Crude Oil

    46.28
    +0.64 (+1.40%)
     
  • Gold

    1,845.00
    +3.90 (+0.21%)
     
  • Silver

    24.25
    +0.12 (+0.49%)
     
  • EUR/USD

    1.2158
    +0.0009 (+0.0729%)
     
  • 10-Yr Bond

    0.9200
    0.0000 (0.00%)
     
  • Vix

    21.28
    +0.11 (+0.52%)
     
  • GBP/USD

    1.3464
    +0.0012 (+0.0875%)
     
  • USD/JPY

    103.8700
    +0.0100 (+0.0096%)
     
  • BTC-USD

    19,333.52
    +75.94 (+0.39%)
     
  • CMC Crypto 200

    379.34
    +4.94 (+1.32%)
     
  • FTSE 100

    6,490.27
    +26.88 (+0.42%)
     
  • Nikkei 225

    26,751.24
    -58.13 (-0.22%)
     

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Mergers; Investors are Encouraged to Contact the Firm – EIDX, WTRE, ARA, CIT

Halper Sadeh LLP
·2 min read

NEW YORK, Nov. 07, 2020 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating:

Eidos Therapeutics, Inc. (NASDAQ: EIDX) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to BridgeBio Pharma, Inc. Under the merger agreement, Eidos stockholders will receive either 1.85 shares of BridgeBio common stock or $73.26 in cash for each share of Eidos common stock owned. If you are an Eidos shareholder, click on this link to learn more about your rights and options: https://halpersadeh.com/actions/eidos-therapeutics-inc-eidx-stock-merger-bridgebio/.

Watford Holdings Ltd. (NASDAQ: WTRE) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Arch Capital Group Ltd. for $35.00 per share. If you are a Watford shareholder, click on this link to learn more about your legal rights and options: https://halpersadeh.com/actions/watford-holdings-ltd-wtre-stock-merger-arch-capital/.

American Renal Associates Holdings, Inc. (NYSE: ARA) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Innovative Renal Care, LLC, an affiliate of Nautic Partners, LLC, for $11.50 per share in cash. If you are an American Renal shareholder, click on this link to learn more about your rights and options: https://halpersadeh.com/actions/american-renal-associates-holdings-inc-ara-stock-merger-nautic/.

CIT Group Inc. (NYSE: CIT) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to First Citizens BancShares, Inc. Under the terms of the merger agreement, CIT shareholders will receive 0.0620 shares of First Citizens class A common stock for each share of CIT common stock they own. If you are a CIT Group shareholder, click on this link to learn more about your legal rights and options: https://halpersadeh.com/actions/cit-group-inc-stock-merger-first-citizens/.

Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com